Optimizing Perfusion Parameters For Intensified Production Of CAR-T Cells In The Ambr 250 High Throughput Bioreactor
Source: Sartorius
Achieving therapeutic doses in CAR-T cell therapies represents the longest phase of manufacturing. In this webinar, we explore scalable expansion processes designed to help meet growing demand.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Sartorius
This website uses cookies to ensure you get the best experience on our website. Learn more